Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Baldwin Investment Management LLC

Baldwin Investment Management LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,743 shares of the medical equipment provider’s stock after acquiring an additional 158 shares during the quarter. Intuitive Surgical accounts for about 0.6% of Baldwin Investment Management LLC’s portfolio, making the stock its 22nd largest position. Baldwin Investment Management LLC’s holdings in Intuitive Surgical were worth $4,786,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. Hazlett Burt & Watson Inc. raised its stake in shares of Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. raised its position in shares of Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after purchasing an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC raised its position in shares of Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares during the last quarter. Meeder Advisory Services Inc. lifted its stake in Intuitive Surgical by 0.3% in the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock valued at $3,629,000 after buying an additional 22 shares in the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC grew its holdings in Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after buying an additional 23 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ISRG. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Mizuho upped their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Truist Financial raised their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $526.06.

Insider Activity at Intuitive Surgical

In related news, General Counsel Gary Loeb sold 300 shares of the firm’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares in the company, valued at $757,625. This trade represents a 15.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. This represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,647 shares of company stock valued at $26,170,907 over the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $542.10 on Wednesday. The firm has a market cap of $193.09 billion, a price-to-earnings ratio of 87.15, a PEG ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $552.00. The stock’s 50-day simple moving average is $506.81 and its 200-day simple moving average is $466.29.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.